KRAS and colorectal carcinoma: TAK-960 was found to inhibit the proliferation of human cancer cell lines regardless of TP53 and KRAS mutation status, including several CRC cell lines, for example, HT-29, HCT116, COLO320DM, HCT-15, RKO, SW480, and SW620.